Allele frequencies in molecularly distinct subgroups of the CLL cohort
CLL subgroup . | Allele frequency . | P vs CLL . | P vs counterpart . | ||
---|---|---|---|---|---|
No. . | C . | G . | |||
Total cohort | 248 | 0.79 | 0.21 | .77 (vs control) | |
IgV mutational status | |||||
MUT | 149 | 0.81 | 0.19 | .57 | .12 |
UM | 87 | 0.76 | 0.24 | .59 | .24 |
CD38 | |||||
Less than 30% | 143 | 0.80 | 0.20 | .37 | .27 |
30% or more | 102 | 0.77 | 0.23 | .76 | .56 |
ZAP-70 | |||||
Less than 20% | 131 | 0.82 | 0.18 | .39 | .03 |
20% or more | 59 | 0.75 | 0.25 | .32 | .07 |
CD38−/ZAP-70− | 88 | 0.83 | 0.17 | .29 | .027 |
CD38+/ZAP-70+ | 35 | 0.74 | 0.26 | .28 | .07 |
MUT/CD38−/ZAP-70− | 73 | 0.84 | 0.16 | .34 | .007 |
UM/CD38+/ZAP-70+ | 25 | 0.72 | 0.28 | .29 | .05 |
Normal/del 13q | 161 | 0.79 | 0.21 | .51 | .16 |
del 11q/del 17p | 43 | 0.74 | 0.26 | .17 | .18 |
CLL subgroup . | Allele frequency . | P vs CLL . | P vs counterpart . | ||
---|---|---|---|---|---|
No. . | C . | G . | |||
Total cohort | 248 | 0.79 | 0.21 | .77 (vs control) | |
IgV mutational status | |||||
MUT | 149 | 0.81 | 0.19 | .57 | .12 |
UM | 87 | 0.76 | 0.24 | .59 | .24 |
CD38 | |||||
Less than 30% | 143 | 0.80 | 0.20 | .37 | .27 |
30% or more | 102 | 0.77 | 0.23 | .76 | .56 |
ZAP-70 | |||||
Less than 20% | 131 | 0.82 | 0.18 | .39 | .03 |
20% or more | 59 | 0.75 | 0.25 | .32 | .07 |
CD38−/ZAP-70− | 88 | 0.83 | 0.17 | .29 | .027 |
CD38+/ZAP-70+ | 35 | 0.74 | 0.26 | .28 | .07 |
MUT/CD38−/ZAP-70− | 73 | 0.84 | 0.16 | .34 | .007 |
UM/CD38+/ZAP-70+ | 25 | 0.72 | 0.28 | .29 | .05 |
Normal/del 13q | 161 | 0.79 | 0.21 | .51 | .16 |
del 11q/del 17p | 43 | 0.74 | 0.26 | .17 | .18 |